SELECT MEDICAL HOLDINGS CORP
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Oct 28, 2026 (2 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 13, 2026 | Mizuho | downgrade | Outperform → Neutral | — | 52% |
| Mar 4, 2026 | Benchmark | downgrade | Buy → Hold | — | 54% |
| Mar 3, 2026 | RBC Capital | downgrade | Outperform → Sector Perform | — | 55% |
| Feb 23, 2026 | RBC Capital | maintain | Outperform → Outperform | $19 | 55% |
| Oct 8, 2025 | RBC Capital | maintain | Outperform → Outperform | $20 | 55% |
| Sep 10, 2025 | B of A Securities | maintain | Buy → Buy | $15 | 53% |
| Aug 4, 2025 | UBS | maintain | Neutral → Neutral | $14 | 54% |
| May 7, 2025 | RBC Capital | maintain | Outperform → Outperform | $19 | 55% |
| Feb 24, 2025 | RBC Capital | maintain | Outperform → Outperform | $23 | 55% |
| Jan 3, 2025 | UBS | maintain | Neutral → Neutral | $21 | 54% |
| Nov 25, 2024 | Benchmark | downgrade | Buy → Hold | $0 | 54% |
| Nov 4, 2024 | RBC Capital | maintain | Outperform → Outperform | $47 | 55% |
| Nov 4, 2024 | Benchmark | reiterate | Buy → Buy | $48 | 54% |
| Nov 1, 2024 | Benchmark | reiterate | Buy → Buy | $48 | 54% |
| Sep 6, 2024 | Benchmark | reiterate | Buy → Buy | $48 | 54% |
| Aug 5, 2024 | Benchmark | reiterate | Buy → Buy | $48 | 54% |
| Aug 2, 2024 | Benchmark | reiterate | Buy → Buy | $48 | 54% |
| Jul 16, 2024 | Benchmark | maintain | Buy → Buy | $48 | 54% |
| May 6, 2024 | RBC Capital | maintain | Outperform → Outperform | $40 | 55% |
| May 6, 2024 | Benchmark | maintain | Buy → Buy | $42 | 54% |
| May 3, 2024 | Benchmark | reiterate | Buy → Buy | $39 | 54% |
| Apr 12, 2024 | Benchmark | reiterate | Buy → Buy | $39 | 54% |
| Nov 30, 2023 | UBS | initiate | — → Neutral | $26 | 54% |
| Nov 8, 2023 | Benchmark | reiterate | Buy → Buy | $39 | 54% |
| Aug 7, 2023 | Credit Suisse | maintain | Neutral → Neutral | $32 | — |
| Jul 20, 2023 | RBC Capital | reiterate | Outperform → Outperform | $38 | 55% |
| May 8, 2023 | RBC Capital | maintain | — → Outperform | $38 | 55% |
| May 8, 2023 | Credit Suisse | reiterate | — → Neutral | $29 | — |
| Feb 27, 2023 | Benchmark | reiterate | — → Buy | $39 | 54% |
| Feb 27, 2023 | Credit Suisse | maintain | — → Neutral | $29 | — |
| Nov 7, 2022 | RBC Capital | maintain | — → Outperform | $32 | 55% |
| May 17, 2022 | Credit Suisse | maintain | — → Neutral | $27 | — |
| May 10, 2022 | RBC Capital | maintain | — → Outperform | $36 | 55% |
| Mar 16, 2022 | Credit Suisse | maintain | — → Neutral | $28 | — |
| Mar 7, 2022 | RBC Capital | maintain | — → Outperform | $42 | 55% |
| Jan 18, 2022 | B of A Securities | maintain | — → Buy | $35 | 53% |
| Jan 18, 2022 | RBC Capital | maintain | — → Outperform | $47 | 55% |
| Aug 10, 2021 | Credit Suisse | maintain | — → Neutral | $39 | — |
| May 10, 2021 | Deutsche Bank | maintain | — → Buy | $46 | 57% |
| Mar 1, 2021 | Credit Suisse | maintain | — → Neutral | $34 | — |
| Jan 5, 2021 | Credit Suisse | maintain | — → Neutral | $27 | — |
| Nov 2, 2020 | Credit Suisse | maintain | — → Neutral | $22 | — |
| Aug 4, 2020 | Deutsche Bank | maintain | — → Buy | $26 | 57% |
| Aug 3, 2020 | Credit Suisse | maintain | — → Neutral | $19 | — |
| Jun 16, 2020 | B of A Securities | downgrade | Neutral → Underperform | $15 | 53% |
| May 4, 2020 | Credit Suisse | maintain | — → Neutral | $18 | — |
| Apr 24, 2020 | Deutsche Bank | maintain | — → Buy | $24 | 57% |
| Apr 3, 2020 | Credit Suisse | maintain | — → Neutral | $23 | — |
| Mar 24, 2020 | Benchmark | reiterate | — → Buy | $25 | 54% |
| Feb 24, 2020 | Deutsche Bank | maintain | — → Buy | $33 | 57% |
No cross-platform signals in the last 90 days